Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × GATA2 Deficiency × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 9 Myeloid 6 Classical hematology 2 Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 2580 Neoplasms, Plasma Cell 515 Lymphoma 376 Lymphoma, Non-Hodgkin 363 Hodgkin Disease 302 Recurrence 298 Leukemia, Lymphocytic, Chronic, B-Cell 294 Precursor Cell Lymphoblastic Leukemia-Lymphoma 273 Leukemia 263 Leukemia, Myeloid, Acute 261 Myelodysplastic Syndromes 236 Lymphoma, Mantle-Cell 215 Lymphoma, Large B-Cell, Diffuse 210 Lymphoma, Follicular 209 Lymphoma, B-Cell, Marginal Zone 188 Burkitt Lymphoma 185 Lymphoma, Large-Cell, Immunoblastic 167 Myeloproliferative Disorders 159 Neoplasms 151 Immunoglobulin Light-chain Amyloidosis 150 Hematologic Neoplasms 142 Primary Myelofibrosis 141 Leukemia, Myeloid, Chronic-Phase 132 Leukemia, Myeloid, Accelerated Phase 125 Lymphoma, T-Cell, Cutaneous 124 Blast Crisis 118 Leukemia, Myelomonocytic, Chronic 116 Waldenstrom Macroglobulinemia 112 Mycosis Fungoides 104 Sezary Syndrome 103

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03018405 2019-09-19

THINK

Celyad Oncology SA

Phase 1/2 Unknown

GATA2 Deficiency, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡